← SynDRA
NVS PAK1 1
SynDRA canonical compound SYN1608730 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | PAK1 |
| Mechanism of action | p21 activated kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- p21 activated kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PTPN1
- PTPN11
- PTPN6
- ACP1
- CDC14A
- DUSP3
- PPP5C
- PTPN22
- PTPN7
- PTPN9
- PTPRA
- PTPRB
- PTPRE
- PTPRF
- PTPRG
- PTPRM
Cross-references
Synonyms
- NVS-PAK1-1
- Nvs-pak1-1
- RefChem:927990
- A1JZR
- C23H25ClF3N5O
- orb1307937
- SCHEMBL27063267
- SCHEMBL30341862
- YQF1582
- EX-A3547
- IWC81674
- BDBM50112348
- MFCD30723183
- AKOS032946524
- CS-6916
- EBC-309070
- NCGC00486944-01
- NCGC00486944-02
- AS-84211
- DA-56346
- NVS-PAK1-1, >=98% (HPLC)
- HY-100519
- NVS-PAK1-1; NVSPAK11; NVS PAK1 1
- T16367
- BDBM50609598
- SCHEMBL31695389
Look up NVS PAK1 1 in the interactive SynDRA portal →